The tariff classification of a “Charger Package Assembly” from China
No Headquarters ruling in this index revokes or modifies this ruling. That is not confirmation that it is still in effect: this index does not hold every Headquarters ruling. Confirm its current status with CBP before relying on it (ruling on CBP CROSS). Text last read from CBP on Nov 21, 2026.
Ruling text
In your letter dated April 9, 2026, you requested a tariff classification ruling on behalf of your client, SetPoint Medical Corporation. The item concerned is referred to as a “Charger Package Assembly” set which consists of a charger, docking station, and carrying case. This assembly is engineered, manufactured, and intended solely for use with the SetPoint System, which is an implantable neuro stimulation medical device indicated for the treatment of rheumatoid arthritis (RA).
In use, the implantable neuro stimulator (not part of this assembly/set) would be housed within a pod and implanted on the left vagus nerve in the patient’s neck. The stimulator delivers targeted electrical stimulation to the cervical vagus nerve. The therapy is intended to reduce RA disease activity, improve patient-reported outcomes, and support disease control. The SetPoint System does not heal or provide a cure for RA; rather, it serves as a means of helping those suffering from RA to live with the condition.
The charger is a wireless device that is worn around the neck. It contains a rechargeable lithium-ion battery and a Bluetooth radio transceiver. The charger is used to charge the implant at home and to program the implant during clinic visits. The charger works together with the programmer, which is an app on an Apple iPad®. Healthcare professionals use the app to program the implant and to turn stimulation off or back on when needed.
The app also shows the healthcare professional important information about the implant and charger, such as how many doses were delivered or missed and the implant’s battery level. Therefore, the charger is used to both charge the implant and to transmit and receive data to and from the implant. The docking station is externally powered through a power supply cord and has a power output not exceeding 50 watts. The docking station’s sole use is for charging and holding the SetPoint System charger.
The carrying case has an outer surface of polyurethane and is specially designed to hold the SetPoint System charger and docking station. Each compartment of the carrying case is uniquely shaped to the specific components of the SetPoint System “Charger Package Assembly”. SetPoint plans to invoice, sell, and import the SetPoint System charger, docking station and carrying case as a set which it refers to as the “Charger Package Assembly”.
It is CBP’s opinion, that the “Charger Package Assembly” meets the criteria of a GRI 3(b) set for classification purposes. As a result, the “Charger Package Assembly” set should be classified as a set under the HTS provision of the component that gives the set its essential character. It is CBP’s opinion that the essential character of this set is imparted by the charger. The charger is used to charge the SetPoint System implant and transmit/receive data to and from the implant in the patient’s neck.
Based on the information supplied, the charger itself would be considered a composite machine as is provided for in Section XVI Note 3. Both the charging functionality (heading 8504), and the data transfer functionality (heading 8517) are equally important to the overall performance of this unit.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N360577).